• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Generalizing the results of cancer clinical trials.

作者信息

Meyer Ralph M

出版信息

J Clin Oncol. 2010 Jan 10;28(2):187-9. doi: 10.1200/JCO.2009.25.8608. Epub 2009 Nov 23.

DOI:10.1200/JCO.2009.25.8608
PMID:19933900
Abstract
摘要

相似文献

1
Generalizing the results of cancer clinical trials.
J Clin Oncol. 2010 Jan 10;28(2):187-9. doi: 10.1200/JCO.2009.25.8608. Epub 2009 Nov 23.
2
Perceived impact of duty hours limits on the fragmentation of patient care: results from an academic health center.对工作时长限制对患者护理碎片化的感知影响：来自一所学术医疗中心的结果
Am J Med. 2005 Jul;118(7):788-93. doi: 10.1016/j.amjmed.2005.04.014.
3
Health-related quality of life and symptom management research sponsored by the National Cancer Institute.由美国国立癌症研究所资助的与健康相关的生活质量和症状管理研究。
J Clin Oncol. 2007 Nov 10;25(32):5128-32. doi: 10.1200/JCO.2007.12.6672.
4
Evaluation of the quality of investigative centers using clinical ratings and compliance data.使用临床评分和合规数据评估研究中心的质量。
Contemp Clin Trials. 2008 Mar;29(2):252-8. doi: 10.1016/j.cct.2007.09.003. Epub 2007 Sep 21.
5
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.关于《预防痴呆症路线图II. 2008年莱昂·索尔研讨会》的评论。阿尔茨海默病卓越中心：是时候更好地整合患者护理与临床研究，以改善阿尔茨海默病的预防和治疗了。
Alzheimers Dement. 2009 Mar;5(2):133-6. doi: 10.1016/j.jalz.2009.01.006.
6
Differences in clinical trial patient attributes and outcomes according to enrollment setting.根据入组设置的不同，临床试验患者特征和结局存在差异。
J Clin Oncol. 2010 Jan 10;28(2):215-21. doi: 10.1200/JCO.2008.21.3652. Epub 2009 Nov 23.
7
[The contribution of clinical research to improved patient care].[临床研究对改善患者护理的贡献]
Ned Tijdschr Geneeskd. 2003 Feb 8;147(6):229-33.
8
Diversity of participants in clinical trials in an academic medical center: the role of the 'Good Study Patient?'.学术医疗中心临床试验参与者的多样性：“优秀研究患者”的作用？
Cancer. 2009 Feb 1;115(3):608-15. doi: 10.1002/cncr.24028.
9
Cancer clinical trial records. Physician responsibility.癌症临床试验记录。医生职责。
Prog Clin Biol Res. 1984;156:369-78.
10
Interventional trials involving patients cannot be performed safely without a control group treated with the standard of care.
Transplantation. 2007 Apr 27;83(8):1137; author reply 1138. doi: 10.1097/01.tp.0000259958.44532.f4.

引用本文的文献

1
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience.乐伐替尼联合帕博利珠单抗治疗转移性或复发性子宫内膜癌脆弱患者的疗效和安全性：单机构经验
Int J Clin Oncol. 2025 Feb;30(2):371-379. doi: 10.1007/s10147-024-02667-0. Epub 2024 Dec 6.
2
Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea.转移性胰腺癌一线化疗的真实世界结局：韩国一项基于全国人群的研究
Cancers (Basel). 2024 Sep 16;16(18):3173. doi: 10.3390/cancers16183173.
3
Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution.
根据临床试验入组情况分析新诊断的不适合移植的多发性骨髓瘤患者的预后：单中心经验
Cancers (Basel). 2023 Nov 2;15(21):5261. doi: 10.3390/cancers15215261.
4
: Navigating the Future With the KGCA Guidelines and Nationwide Surveys.借助KGCA指南和全国性调查引领未来。
J Gastric Cancer. 2023 Oct;23(4):509-511. doi: 10.5230/jgc.2023.23.e39.
5
Harnessing Real-World Evidence to Advance Cancer Research.利用真实世界证据推进癌症研究。
Curr Oncol. 2023 Feb 2;30(2):1844-1859. doi: 10.3390/curroncol30020143.
6
External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort.两种既定临床风险评分对全国队列中结直肠癌肝转移局部治疗后结局预测的外部验证
Cancers (Basel). 2022 May 10;14(10):2356. doi: 10.3390/cancers14102356.
7
Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018.2014 年至 2018 年在英国引入免疫检查点抑制剂后转移性黑色素瘤患者的结局。
Int J Cancer. 2021 Feb 15;148(4):868-875. doi: 10.1002/ijc.33266. Epub 2020 Sep 12.
8
Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes.比较接受抗 HER2 治疗的转移性乳腺癌患者的基于人群队列的临床结局与临床试验结局。
Breast Cancer Res Treat. 2020 May;181(1):155-165. doi: 10.1007/s10549-020-05614-5. Epub 2020 Mar 31.
9
Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system.使用美国食品和药物管理局不良事件报告系统评估 vedolizumab 的真实世界安全性概况。
PLoS One. 2019 Dec 4;14(12):e0225572. doi: 10.1371/journal.pone.0225572. eCollection 2019.
10
Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis.真实世界中 FOLFIRINOX 对比吉西他滨和白蛋白紫杉醇在晚期胰腺癌中的疗效：基于人群的倾向评分加权分析。
Cancer Med. 2020 Jan;9(1):160-169. doi: 10.1002/cam4.2705. Epub 2019 Nov 13.